$139.19M | |
$5.95 | |
$710.11 | |
$3.53 | |
$6.02 | |
$-0.35 | |
-5.81% | |
84K |
Precision BioSciences, Inc. (DTIL) is currently trading at $5.63 as of 2026-03-30 16:15:00, reflecting a -5.81% move ($-0.35) from the previous close.
In the short term, the stock has returned +30.00% over the past four weeks. Over the last 12 months, Precision BioSciences, Inc. has recorded a +18.01% price change, indicating a stable performance relative to the broader market.
Over the past seven days, Precision BioSciences, Inc. has traded within a short-term range shaped by market sentiment in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. During this period, the stock moved from its previous closing price of $6.48 to the latest recorded price of $5.63, reflecting an intraday change of -5.81%. Daily movements highlight shifts in trading volume (84,166), investor positioning, and reactions to macroeconomic updates.
From a momentum standpoint, DTIL has delivered a +30.00% return over the past month and a +18.01% change in the last 12 months, indicating a stable trend relative to its broader sector peers.
You can buy and trade DTIL on MEXC in three simple steps:
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 68 |
| Sector | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Company Website |
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Amount
1 DTIL = 5.629 USD